Maanshan People's Hospital

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Childhood cancers1 trial
• Lung cancer1 trial
• Metastatic breast cancer1 trial

Phase

• Phase 21 trial
• Phase 31 trial

Status

• Active, not recruiting1 trial
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Chia Tai Tianqing Pharmaceutical Group Co., Ltd.1 trial
• CSPC ZhongQi Pharmaceutical Technology Co., Ltd.1 trial
• Jiangsu Simcere Pharmaceutical Co., Ltd.1 trial

Running trials

• Active, not recruiting

  A Study of SIM0270 Combined With Everolimus vs. Treatment of Physician's Choice in Patients With ER+/HER2- Advanced Breast Cancer (SIMRISE)

  NCT06680921· Phase 3· Jiangsu Simcere Pharmaceutical Co., Ltd.· Source

Closed trials

• Terminated

  Carboplatin/Cisplatin + Etoposide + Benmelstobart Sequential Benmelstobart Combined With Anlotinib Versus Carboplatin/Cisplatin + Etoposide + Tislelizumab Sequential Tislelizumab in the Treatment of Extensive Stage Small Cell Lung Cancer

  NCT06897579· Phase 2· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.· Source

• Completed

  Real-world Study for the Safety of Albumin-Bound Paclitaxel in Malignant Tumors

  NCT04060290· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.· Source